The results also demonstrated that MAL2 knockdown can decrease the phosphorylation levels of RPS6, mTOR and ERK (Fig. 3D).Taken together, the findings indicate that MAL2 could activate mTORC1 signaling in NSCLC. The gene discussed is RPS6; the disease is non-small cell lung carcinoma.